Association between maternal and perinatal outcomes and histological changes in the placenta of patients with Covid-19: A cohort study.

Although studies evaluated placental involvement in Covid-19 patients, few have assessed its association with clinical repercussions. The study aimed to determine the association between the clinical status and maternal and perinatal outcomes of patients with Covid-19 at delivery and changes in placental histology. It is so far the largest cohort evaluating placentas of patients infected by the SARS-CoV-2.

Effects of an instructional design based postpartum hemorrhage simulation training on patient outcomes: an uncontrolled before-and-after study.

To compare postpartum hemorrhage (PPH) patient outcomes before and after an instructional design based PPH simulation attended by obstetrics and gynecology (OBGYN) residents. This uncontrolled before-and-after study was conducted in Recife, Brazil including all 1388 women delivering from June to August 2012 and all 1357 delivering from June to August 2013. The 36 OBGYN residents were divided into13 teams of two or three participants and were trained through ID based PPH simulation training with the following eight steps: (1) prior knowledge activation, (2) video demonstration, (3) dual-coding PPH protocol discussion-an image association during the training, (4) training scenario # 1, (5) debriefing, (6) training scenario # 2 with immediate feedback, (7) training scenario # 3, and (8) debriefing with self-assessment.

Self-perceived long-term transfer of learning after postpartum hemorrhage simulation training.

Objective: To explore long-term transfer (application of acquired knowledge and skills on the job) after postpartum hemorrhage simulation training based on either instructional design (ID) principles or conventional best practice.

Methods: In this qualitative study, semi-structured interviews with obstetrics and gynecology healthcare practitioners were conducted between August 7 and September 26, 2015, in Recife, Brazil. The participants were randomly selected from each of two postpartum hemorrhage simulations attended 2 years earlier (one ID and one conventional best practice).

Evaluation of perinatal outcomes in pregnant women with preterm premature rupture of membranes.

Objective: To determine the association between amniotic fluid index (AFI) and perinatal outcomes in preterm premature rupture of membranes (PPROM).

Method: A retrospective cohort study was conducted between 2008 and 2012. 86 pregnant women were included, with a diagnosis of PPROM and gestational age from 24 to 35 weeks.

[Amniotic fluid volume and maternal outcomes in women with preterm premature rupture of membranes].

Purpose: To describe the potential influence of amniotic fluid on the maternal outcome of preterm premature rupture of membranes (PROM).

Methods: An observational, retrospective cohort study was conducted between December 2012 and January 2008 on 86 pregnant women with preterm PROM and a gestational age (GA) of 24 to 35 weeks. The amniotic fluid index (AFI) was used to measure aminiotic fluid volume.

Uterine artery Doppler in the third trimester of pregnancy and postnatal outcome of patients with severe preeclampsia.

Objectives: To assess uterine artery Doppler velocimetry performed in the third trimester of pregnancy in women with severe preeclampsia as a predictor of adverse postpartum outcome.

Methods: A cohort study including 154 women, conducted in a teaching hospital in Recife, Brazil. Uterine artery Doppler was performed at admission to hospital and postpartum outcome was evaluated.

[Epidemiological profile and postpartum outcome in severe preeclampsia].

Background: To describe maternal characteristics and blood pressure behavior in the puerperium of women admitted, during pregnancy, with diagnosis of severe preeclampsia.

Methods: A cohort study was conducted including pregnant women with gestational age of 28 weeks or more, with diagnosis of preeclampsia, not in labor, at the Instituto Materno Infantil Professor Fernando Figueira (IMIP) from November 2006 to September 2007. Patients with chronic hypertension, autoimmune diseases, gestational diabetes, multiple pregnancy and signs of clinical instability were excluded.